Technical Analysis for TRXPF - Torii Pharmaceutical

Grade Last Price % Change Price Change
grade B 25.5 -1.44% -0.3720
TRXPF closed down 1.44 percent on Monday, November 4, 2019, on 38 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical TRXPF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -1.44%
Gapped Up Strength -1.44%
Up 3 Days in a Row Strength -1.44%
Narrow Range Bar Range Contraction -0.39%
Gapped Up Strength -0.39%
Volume Surge Other 3.24%
Narrow Range Bar Range Contraction 3.24%
Gapped Up Strength 3.24%
Older signals for TRXPF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products. The company's products include REMITCH, an agent used for the treatment of pruritus in hemodialysis patients; Truvada, an antiretroviral agent used for the treatment of human immunodeficiency virus (HIV); ANTEBATE, an agent used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; Riona, a therapeutic agent for hyperphosphatemia; and Stribild combination tablets for the treatment HIV. It also provides FUTHAN for injection, an anticoagulant drug used during hemodiafiltration; KAYEXALATE, a therapeutic agent for hyperkalemia treatment; and URINORM, an uricosuric agent. In addition, the company offers LOCOID, an agent used for the treatment of the inflammatory manifestations of dermatosis; and ZEFNART, a topical antifungal agent. Further, it provides CEDARTOLEN, a sublingual immunotherapy drug; MITICURE, an allergen immunotherapy tablet; Genvoya combination tablets for the treatment of HIV-1 infection; Descovy, an antiviral agent for HIV; Bio-Three viable bacterial preparations; URINORM, a renal diseases and hemodialysis uricosuric agent; and Magsent used for the treatment for premature labor Eclampsia-suppressing. Torii Pharmaceutical Co., Ltd. has collaboration with Japan Tobacco Inc. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Chemistry Medicine RTT Pharmaceutical Products Organic Compounds Immunotherapy Infection Inflammation Hiv Atopic Dermatitis Hepatotoxins Hemodialysis Skin Diseases Treatment Of Hiv Allergen Immunotherapy Pruritus Gilead Sciences Hemodiafiltration Hyperphosphatemia Prevention Of Hiv/Aids Renal Diseases Tenofovir Alafenamide Treatment Of Skin Diseases

Is TRXPF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 28.85
52 Week Low 23.5
Average Volume 260
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 25.3432
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.5000
Resistance 3 (R3) 25.5000 25.5000 25.5000
Resistance 2 (R2) 25.5000 25.5000 25.5000 25.5000
Resistance 1 (R1) 25.5000 25.5000 25.5000 25.5000 25.5000
Pivot Point 25.5000 25.5000 25.5000 25.5000 25.5000
Support 1 (S1) 25.5000 25.5000 25.5000 25.5000 25.5000
Support 2 (S2) 25.5000 25.5000 25.5000 25.5000
Support 3 (S3) 25.5000 25.5000 25.5000
Support 4 (S4) 25.5000